Share this article
Online Research Marketplace Adds Blockchain Verification Service
Online research marketplace Scientist.com has launched a blockchain-based data verification platform for the biopharma industry.
Updated Sep 13, 2021, 7:53 a.m. Published May 1, 2018, 6:00 a.m.
Scientist.com, an online marketplace for outsourced research, has launched a blockchain-based data verification platform, the company announced on Monday.
Dubbed DataSmart, the platform will allow biotechnology and pharmaceutical companies to demonstrate the veracity of electronically submitted research data to regulators - specifically that which companies obtain during the preclinical and clinical stages of drug development.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
"In biopharma research we need blockchain technology to verify and validate the supply chain and to ensure the integrity of research data," Chris Petersen, Scientist.com's CTO and founder said in a statement, adding:
"Our new DataSmart platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered."
The company said the service will specifically help biopharmaceutical firms comply with 21CFR Part 11, a regulation that outlines the standards electronic records must meet in order for the U.S. Food and Drug Administration to consider them reliable and equivalent to paper records.
"The cost and time spent adhering to 21CFR Part 11 has made it prohibitive to ensure data integrity at earlier stages of the drug discovery and development process," Scientist.com CEO and founder Kevin Lustig said in the statement.
Big pharma firms Pfizer, Amgen and Sanofi also started exploring blockchain applications to the industry in January. The companies are specifically pursuing use cases related to data management and movement and patient communication automation among others.
Pills image via Shutterstock
More For You
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
BNB drops nearly 3% to as bitcoin whipsaw and tech selloff hit crypto market
The decline was accompanied by sharp volatility in bitcoin and weakness in U.S. tech stocks, suggesting a return of risk-off sentiment.
What to know:
- BNB fell nearly 3% to around $844 over the past 24 hours, breaking below the $855-$857 support area and experiencing heavy selling pressure.
- The decline was accompanied by sharp volatility in bitcoin and weakness in U.S. tech stocks.
- To avoid a deeper decline towards $830, BNB needs to hold above $840, while a recovery above $855 would be needed to stabilize the trend and reopen a path towards $870.
Top Stories
